The country’s first indigenous mRNA Covid-19 vaccine candidate has received approval from Indian drug regulators to initiate Phase I/II human clinical trials. The mRNA vaccine candidate – HGCO19 – has been developed by Pune-based company Gennova, and is supported with a seed grant under the Ind-CEPI mission of the Department of Biotechnology under the Ministry of Science and Technology.